Billionaire investor Mark Cuban took another shot at Commerce Secretary Howard Lutnick in his latest post. Over the weekend, Cuban took to Bluesky to mock Lutnick, writing, "I wonder which Time Share company Howard Lutnick is going to get a job in sales at."
Mode Mobile developed a smartphone called EarnPhone, which allows users to earn and save money by playing video games, listening to music and reading the news. With the phone priced at an affordable $99, the barriers to adoption are low.
Earning Opportunity for All Smartphone Users
Mode EarnPhone
State-of-the-art smartphone device includes built-in earning features.
EarnOS
Proprietary earning software turns smartphones into EarnPhones.
Lutnick’s Controversial Tenure
Cuban’s jab comes on the heels of a series of critical comments he’s made about Lutnick's tenure as commerce secretary. In March, for instance, Cuban questioned Lutnick’s effectiveness, asking, "Has Howard Lutnick done anything of value as Commerce Secretary?" The remark was a response to Lutnick’s recent controversial interviews and public comments.
Don't Miss:
- ‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. You can invest today for just $0.30/share with a $1000 minimum.
- Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — this is your last chance to become an investor for $0.80 per share.
One of the key points of contention is Lutnick’s approach to tariffs and trade. In a March CNBC interview, Lutnick defended the Trump administration's tariff strategy, emphasizing its potential to boost U.S. manufacturing. Cuban shot back on Bluesky, saying, "Someone needs to explain to our Sec of Commerce how capitalism works." He added, "America has a global trade surplus on services. Services have the highest margins and profits of our exports. That is where capital and expertise are focused."
Cuban's critiques highlight a fundamental disagreement over the direction of U.S. trade policy. Lutnick has been a vocal supporter of President Donald Trump’s tariffs, arguing that they are necessary to address the $1.2 trillion U.S. trade deficit. He defended this approach in a Sunday CNN interview, describing the deficit as unsustainable and claiming that tariffs will help create balanced trade. "The president wants balanced and fair trade, and tariffs are the tool to create balanced and fair trade," Lutnick said.
Trending: The team behind $6B+ in licensing deals is now building the next billion-dollar IP empire — invest early at $2.25/share.
Cuban has consistently resisted this, arguing that the U.S. should concentrate more on its robust services industry, which he claims is more lucrative and a better long-term investment for economic expansion. He also criticized Lutnick’s recent comments about Social Security, where Lutnick suggested that people who complain about missed checks might be fraudsters, sparking significant backlash.
"My mother-in-law, who’s 94, she wouldn’t call and complain. She just wouldn’t," Lutnick said on the "All-In Podcast" in March. "A fraudster always makes the loudest noise, screaming, yelling and complaining."
The latest trade developments also add context to Cuban’s criticism. This week, the U.S. and China agreed to a 90-day tariff reduction pause, with the U.S. lowering tariffs on Chinese goods from 145% to 30% and China cutting duties on U.S. products from 125% to 10%. The deal, which allows for ongoing economic discussions, underscores the ongoing challenges in balancing U.S. trade interests.
Cuban’s pointed comments suggest he remains skeptical of Lutnick's approach, framing it as disconnected from the economic realities faced by most Americans. His critiques echo broader concerns about the potential economic fallout from ongoing trade disputes and the effectiveness of tariffs as a long-term strategy.
Read Next:
- Be part of the next med-tech breakthrough for only $350 — 500+ surgeries already done with nView's AI system.
- Invest Where It Hurts — And Help Millions Heal: Invest in Cytonics and help disrupt a $390B Big Pharma stronghold.
Image: Shutterstock
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
